Shovlin Claire L, Chamali Basel, Santhirapala Vatshalan, Livesey John A, Angus Gillian, Manning Richard, Laffan Michael A, Meek John, Tighe Hannah C, Jackson James E
National Heart & Lung Institute (NHLI) Cardiovascular Sciences, Imperial College London, United Kingdom.
National Heart & Lung Institute (NHLI) Cardiovascular Sciences, Imperial College London, United Kingdom ; Imperial College School of Medicine, Imperial College London, United Kingdom.
PLoS One. 2014 Feb 19;9(2):e88812. doi: 10.1371/journal.pone.0088812. eCollection 2014.
Pulmonary first pass filtration of particles marginally exceeding ∼7 µm (the size of a red blood cell) is used routinely in diagnostics, and allows cellular aggregates forming or entering the circulation in the preceding cardiac cycle to lodge safely in pulmonary capillaries/arterioles. Pulmonary arteriovenous malformations compromise capillary bed filtration, and are commonly associated with ischaemic stroke. Cohorts with CT-scan evident malformations associated with the highest contrast echocardiographic shunt grades are known to be at higher stroke risk. Our goal was to identify within this broad grouping, which patients were at higher risk of stroke.
497 consecutive patients with CT-proven pulmonary arteriovenous malformations due to hereditary haemorrhagic telangiectasia were studied. Relationships with radiologically-confirmed clinical ischaemic stroke were examined using logistic regression, receiver operating characteristic analyses, and platelet studies.
Sixty-one individuals (12.3%) had acute, non-iatrogenic ischaemic clinical strokes at a median age of 52 (IQR 41-63) years. In crude and age-adjusted logistic regression, stroke risk was associated not with venous thromboemboli or conventional neurovascular risk factors, but with low serum iron (adjusted odds ratio 0.96 [95% confidence intervals 0.92, 1.00]), and more weakly with low oxygen saturations reflecting a larger right-to-left shunt (adjusted OR 0.96 [0.92, 1.01]). For the same pulmonary arteriovenous malformations, the stroke risk would approximately double with serum iron 6 µmol/L compared to mid-normal range (7-27 µmol/L). Platelet studies confirmed overlooked data that iron deficiency is associated with exuberant platelet aggregation to serotonin (5HT), correcting following iron treatment. By MANOVA, adjusting for participant and 5HT, iron or ferritin explained 14% of the variance in log-transformed aggregation-rate (p = 0.039/p = 0.021).
These data suggest that patients with compromised pulmonary capillary filtration due to pulmonary arteriovenous malformations are at increased risk of ischaemic stroke if they are iron deficient, and that mechanisms are likely to include enhanced aggregation of circulating platelets.
在诊断中,通常会利用肺部对略大于7微米(红细胞大小)的颗粒进行首过过滤,这能使在前一心跳周期中形成或进入循环的细胞聚集体安全地滞留在肺毛细血管/小动脉中。肺动静脉畸形会损害毛细血管床过滤功能,并且通常与缺血性中风相关。已知CT扫描显示有明显畸形且超声心动图分流分级最高的患者队列中风风险更高。我们的目标是在这个宽泛的分组中确定哪些患者中风风险更高。
对497例经CT证实因遗传性出血性毛细血管扩张症导致肺动静脉畸形的连续患者进行了研究。使用逻辑回归、受试者工作特征分析和血小板研究来检查与经放射学证实的临床缺血性中风的关系。
61名个体(12.3%)发生了急性、非医源性缺血性临床中风,中位年龄为52岁(四分位间距41 - 63岁)。在粗逻辑回归和年龄调整后的逻辑回归中,中风风险与静脉血栓栓塞或传统神经血管危险因素无关,而是与低血清铁有关(调整后的比值比为0.96 [95%置信区间0.92, 1.00]),与反映较大右向左分流的低氧饱和度的关联较弱(调整后的比值比为0.96 [0.92, 1.01])。对于相同的肺动静脉畸形,与血清铁处于正常范围(7 - 27微摩尔/升)的患者相比,血清铁为6微摩尔/升时中风风险大约会增加一倍。血小板研究证实了被忽视的数据,即缺铁与血小板过度聚集至血清素(5HT)有关,铁治疗后可得到纠正。通过多变量方差分析,在对参与者和5HT进行调整后,铁或铁蛋白解释了对数转换后的聚集率方差的14%(p = 0.039/p = 0.021)。
这些数据表明,因肺动静脉畸形导致肺毛细血管过滤功能受损的患者如果缺铁,缺血性中风风险会增加,其机制可能包括循环血小板聚集增强。